Company overview
| Company name | Noile-Immune Biotech Inc. |
| Office address | Headquarters: T&G Hamamatsucho Building, 5th fl., 2-12-10 Shiba-Daimon, Minato-ku, Tokyo, Japan Yamaguchi Office & Laboratory: Faculty of Medicine and Health Sciences, Yamaguchi University, 1-1-1 Minami-kogushi, Ube, Yamaguchi, Japan Shonan Laboratory: Shonan Health Innovation Park, 2-26-1 Muraoka-higashi, Fujisawa, Kanagawa, Japan |
| Founded | April 16, 2015 |
| Representative | Koji Tamada, M.D., Ph.D.(Representative Director and CEO) |
| Capital stock | 4,047 million yen（as of the end of June 2024） |
| Accounting period | December 31 |
| Business description | Development of novel cancer immunotherapies mainly using CAR T cells |
| Number of employees | 30 (as of the end of June 2024) |
